Ception Therapeutics

Company: Ception Therapeutics

Financing: $77M
Website: http://www.ceptiontx.com/

After gaining an impressive $63 million in the first tranche of its third round in January, Malvern, PA-based Ception upped the ante by gaining an additional $14.7 in its second tranche in May, bringing the grand total to $77 million in its third round. Participants included Essex Woodlands Health Ventures, Third Point and Greenlight Capital. Ception’s pipeline includes a late-stage biologic agent in clinical development for multiple inflammatory conditions, a small molecule anti-TNF program and other discovery programs. The company plans to use the money to advance its lead compound as well as support development of earlier-stage drug targets.

Related Article:
Ception Therapeutics pockets $63M in third round. Report


Ception Therapeutics

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.